GILEAD SEES FY PRODUCT SALES OF $30.1 BLN-$30.4 BLN VERSUS $30.06 BLN EXPECTED AND AN FY ADJUSTED LOSS PER SHARE OF 30C-65C, WHILE CUTTING ITS FY VEKLURY REVENUE OUTLOOK TO $300 MLN FROM $600 MLN.
متن اصلی؛ ترجمهٔ فارسی ندارد
متن اصلی؛ ترجمهٔ فارسی ندارد
